CADL
Candel Therapeutics Inc
10.20$
-2.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.28 | -0.48 | -1.18 | -1.09 | -1.18 | -0.85 | -0.72 | |
| 0.00 | 0.00 | 0.01 | 0.03 | 0.03 | 0.03 | 0.02 | |
| 0.02 | 0.11 | 0.16 | 0.08 | 0.11 | 0.17 | 0.07 | |
| 0.13 | 0.36 | 0.77 | -0.48 | – | – | – | |
| 0.03 | 0.09 | -0.05 | 0.00 | -0.02 | 0.01 | 0.04 | |
| 0.01 | 0.08 | 0.10 | 0.04 | 0.02 | 0.00 | 0.01 | |
| -1.91 | 2.05 | -0.10 | -0.04 | -0.01 | 0.00 | -0.01 | |
| – | – | 3.80 | – | 0.00 | – | – | |
| -0.03 | 0.02 | 1.05 | 0.69 | 0.00 | -0.29 | 0.68 | |
| 1.17 | 0.03 | 3.80 | 0.69 | 0.00 | 2.98 | 1.06 | |
| -1.01 | 1.60 | 2.53 | -0.44 | -1.20 | 2.12 | 0.33 | |
| -0.29 | -0.56 | -1.27 | -1.14 | -1.20 | -0.85 | -0.73 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.